Lymphoid enhancer-binding factor 1: Difference between revisions
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
+OA URL https://zenodo.org/record/895454 |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | |||
}} | |||
'''Lymphoid enhancer-binding factor 1''' ('''LEF1''') is a [[protein]] that in humans is encoded by the ''LEF1'' [[gene]].<ref name="pmid1783375">{{cite journal |vauthors=Milatovich A, Travis A, Grosschedl R, Francke U | title = Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf | journal = Genomics | volume = 11 | issue = 4 | pages = 1040–8 |date=Mar 1992 | pmid = 1783375 | pmc = | doi =10.1016/0888-7543(91)90030-I }}</ref> | |||
| | |||
== Function == | |||
Lymphoid enhancer-binding factor-1 (LEF1) is a 48-kD nuclear protein that is expressed in pre-[[B cell|B]] and [[T cell]]s. It binds to a functionally important site in the T-cell receptor-alpha ([[TRA@|TCRA]]) enhancer and confers maximal enhancer activity. LEF1 belongs to a family of regulatory proteins that share homology with high mobility group protein-1 ([[HMGB1|HMG1]]).<ref name="entrez">{{cite web | title = Entrez Gene: LEF1 lymphoid enhancer-binding factor 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51176| accessdate = }}</ref> | |||
}} | == Clinical significance == | ||
LEF1 is highly overexpressed and associated with disease progression and poor prognosis in [[B-cell chronic lymphocytic leukemia]].<ref name = "Erdfelder et al.">{{cite journal |vauthors=Erdfelder F, Hertweck M, Filipovich A, Uhrmacher S, Kreuzer KA | title = High lymphoid enhancer- binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia| journal = Hematology Reports| volume = 2| issue = 1| page = 3| year = 2010 | month = | pmid = | pmc = | doi = 10.4081/hr.2010.e3| url = http://www.pagepress.org/journals/index.php/hr/article/view/hr.2010.e3 | issn = }}</ref> It is also a promising potential drug target.<ref name="pmid20360943">{{cite journal |vauthors=Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA | title = Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo | journal = Neoplasia | volume = 12 | issue = 4 | pages = 326–35 |date=April 2010 | pmid = 20360943 | pmc = 2847740 | doi = | url = | issn = }}</ref> | |||
==Interactions== | |||
Lymphoid enhancer-binding factor 1 has been shown to [[Protein-protein interaction|interact]] with: | |||
* [[ALX4]],<ref name="pmid11696550">{{cite journal |vauthors=Boras K, Hamel PA | title = Alx4 binding to LEF-1 regulates N-CAM promoter activity | journal = J. Biol. Chem. | volume = 277 | issue = 2 | pages = 1120–7 |date=January 2002 | pmid = 11696550 | doi = 10.1074/jbc.M109912200 }}</ref> | |||
* [[Runt-related transcription factor 1|AML-1]],<ref name="pmid10617663">{{cite journal |vauthors=Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW | title = A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia | journal = J. Biol. Chem. | volume = 275 | issue = 1 | pages = 651–6 |date=January 2000 | pmid = 10617663 | doi =10.1074/jbc.275.1.651 }}</ref> | |||
* [[Beta-catenin|CTNNB1]],<ref name="pmid15684397">{{cite journal |vauthors=Edlund S, Lee SY, Grimsby S, Zhang S, Aspenström P, Heldin CH, Landström M | title = Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis | journal = Mol. Cell. Biol. | volume = 25 | issue = 4 | pages = 1475–88 |date=February 2005 | pmid = 15684397 | pmc = 548008 | doi = 10.1128/MCB.25.4.1475-1488.2005 }}</ref><ref name="pmid12748295">{{cite journal |vauthors=Grueneberg DA, Pablo L, Hu KQ, August P, Weng Z, Papkoff J | title = A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway | journal = Mol. Cell. Biol. | volume = 23 | issue = 11 | pages = 3936–50 |date=June 2003 | pmid = 12748295 | pmc = 155208 | doi =10.1128/MCB.23.11.3936-3950.2003 }}</ref><ref name="pmid8757136">{{cite journal |vauthors=Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W | title = Functional interaction of beta-catenin with the transcription factor LEF-1 | journal = Nature | volume = 382 | issue = 6592 | pages = 638–42 |date=August 1996 | pmid = 8757136 | doi = 10.1038/382638a0 }}</ref><ref name="pmid10890911">{{cite journal |vauthors=Labbé E, Letamendia A, Attisano L | title = Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 97 | issue = 15 | pages = 8358–63 |date=July 2000 | pmid = 10890911 | pmc = 26952 | doi = 10.1073/pnas.150152697 }}</ref> | |||
* [[EP300]],<ref name="pmid12446687">{{cite journal |vauthors=Hecht A, Stemmler MP | title = Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4 | journal = J. Biol. Chem. | volume = 278 | issue = 6 | pages = 3776–85 |date=February 2003 | pmid = 12446687 | doi = 10.1074/jbc.M210081200 }}</ref> | |||
* [[Microphthalmia-associated transcription factor|MITF]]<ref name="pmid12032083">{{cite journal |vauthors=Yasumoto K, Takeda K, Saito H, Watanabe K, Takahashi K, Shibahara S | title = Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling | journal = EMBO J. | volume = 21 | issue = 11 | pages = 2703–14 |date=June 2002 | pmid = 12032083 | pmc = 126018 | doi = 10.1093/emboj/21.11.2703 }}</ref> | |||
* [[PIAS4]],<ref name="pmid11731474">{{cite journal |vauthors=Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R | title = PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies | journal = Genes Dev. | volume = 15 | issue = 23 | pages = 3088–103 |date=December 2001 | pmid = 11731474 | pmc = 312834 | doi =10.1101/gad.944801 }}</ref> | |||
* [[Mothers against decapentaplegic homolog 2|SMAD2]],<ref name=pmid10890911/> and | |||
* [[Mothers against decapentaplegic homolog 3|SMAD3]].<ref name=pmid10890911/> | |||
==References== | ==References== | ||
{{ | {{Reflist}} | ||
==Further reading== | ==Further reading== | ||
{{ | {{Refbegin|2}} | ||
*{{cite journal | author=Waterman ML |title=Lymphoid enhancer factor/T cell factor expression in colorectal cancer. |journal=Cancer Metastasis Rev. |volume=23 |issue= 1–2 |pages= 41–52 |year= 2004 |pmid= 15000148 |doi=10.1023/A:1025858928620|url=https://zenodo.org/record/895454 }} | |||
*{{cite journal |vauthors=Skokowa J, Welte K |title=LEF-1 is a decisive transcription factor in neutrophil granulopoiesis |journal=Ann. N. Y. Acad. Sci. |volume=1106 |issue= |pages= 143–51 |year= 2007 |pmid= 17360796 |doi= 10.1196/annals.1392.012 }} | |||
*{{cite journal | author=Waterman ML |title=Lymphoid enhancer factor/T cell factor expression in colorectal cancer. |journal=Cancer Metastasis Rev. |volume=23 |issue= | *{{cite journal |vauthors=Travis A, Amsterdam A, Belanger C, Grosschedl R |title=LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected] |journal=Genes Dev. |volume=5 |issue= 5 |pages= 880–94 |year= 1991 |pmid= 1827423 |doi=10.1101/gad.5.5.880 }} | ||
*{{cite journal | | *{{cite journal |vauthors=van de Wetering M, Oosterwegel M, Dooijes D, Clevers H |title=Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box |journal=EMBO J. |volume=10 |issue= 1 |pages= 123–32 |year= 1991 |pmid= 1989880 |doi= | pmc=452620 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Waterman ML, Fischer WH, Jones KA |title=A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer |journal=Genes Dev. |volume=5 |issue= 4 |pages= 656–69 |year= 1991 |pmid= 2010090 |doi=10.1101/gad.5.4.656 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Zhou P, Byrne C, Jacobs J, Fuchs E |title=Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate |journal=Genes Dev. |volume=9 |issue= 6 |pages= 700–13 |year= 1995 |pmid= 7537238 |doi=10.1101/gad.9.6.700 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides |journal=Gene |volume=138 |issue= 1–2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Prieve MG, Guttridge KL, Munguia JE, Waterman ML |title=The nuclear localization signal of lymphoid enhancer factor-1 is recognized by two differentially expressed Srp1-nuclear localization sequence receptor proteins |journal=J. Biol. Chem. |volume=271 |issue= 13 |pages= 7654–8 |year= 1996 |pmid= 8631802 |doi=10.1074/jbc.271.13.7654 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Behrens J, von Kries JP, Kühl M, etal |title=Functional interaction of beta-catenin with the transcription factor LEF-1 |journal=Nature |volume=382 |issue= 6592 |pages= 638–42 |year= 1996 |pmid= 8757136 |doi= 10.1038/382638a0 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Bagga R, Emerson BM |title=An HMG I/Y-containing repressor complex and supercoiled DNA topology are critical for long-range enhancer-dependent transcription in vitro |journal=Genes Dev. |volume=11 |issue= 5 |pages= 629–39 |year= 1997 |pmid= 9119227 |doi=10.1101/gad.11.5.629 }} | ||
*{{cite journal | *{{cite journal |vauthors=Bruhn L, Munnerlyn A, Grosschedl R |title=ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function |journal=Genes Dev. |volume=11 |issue= 5 |pages= 640–53 |year= 1997 |pmid= 9119228 |doi=10.1101/gad.11.5.640 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Brannon M, Gomperts M, Sumoy L, etal |title=A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus |journal=Genes Dev. |volume=11 |issue= 18 |pages= 2359–70 |year= 1997 |pmid= 9308964 |doi=10.1101/gad.11.18.2359 | pmc=316518 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, etal |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library |journal=Gene |volume=200 |issue= 1–2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3 }} | ||
*{{cite journal | *{{cite journal |vauthors=Korinek V, Barker N, Willert K, etal |title=Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse |journal=Mol. Cell. Biol. |volume=18 |issue= 3 |pages= 1248–56 |year= 1998 |pmid= 9488439 |doi= | pmc=108837 }} | ||
*{{cite journal | *{{cite journal |vauthors=Prieve MG, Guttridge KL, Munguia J, Waterman ML |title=Differential importin-alpha recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1 |journal=Mol. Cell. Biol. |volume=18 |issue= 8 |pages= 4819–32 |year= 1998 |pmid= 9671491 |doi= | pmc=109067 }} | ||
*{{cite journal | *{{cite journal |vauthors=Levanon D, Goldstein RE, Bernstein Y, etal |title=Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=95 |issue= 20 |pages= 11590–5 |year= 1998 |pmid= 9751710 |doi=10.1073/pnas.95.20.11590 | pmc=21685 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Hovanes K, Li TW, Waterman ML |title=The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing |journal=Nucleic Acids Res. |volume=28 |issue= 9 |pages= 1994–2003 |year= 2000 |pmid= 10756202 |doi=10.1093/nar/28.9.1994 | pmc=103301 }} | ||
*{{cite journal | *{{cite journal |vauthors=Labbé E, Letamendia A, Attisano L |title=Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=97 |issue= 15 |pages= 8358–63 |year= 2000 |pmid= 10890911 |doi= 10.1073/pnas.150152697 | pmc=26952 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Brantjes H, Roose J, van De Wetering M, Clevers H |title=All Tcf HMG box transcription factors interact with Groucho-related co-repressors |journal=Nucleic Acids Res. |volume=29 |issue= 7 |pages= 1410–9 |year= 2001 |pmid= 11266540 |doi=10.1093/nar/29.7.1410 | pmc=31284 }} | ||
*{{cite journal | | {{Refend}} | ||
*{{cite journal | | |||
}} | |||
{{ | |||
== External links == | == External links == | ||
* {{MeshName|LEF1+protein,+human}} | * {{MeshName|LEF1+protein,+human}} | ||
{{NLM content}} | |||
{{PDB Gallery|geneid=51176}} | |||
{{Transcription factors|g4}} | |||
[[Category:Transcription factors]] | [[Category:Transcription factors]] |
Revision as of 08:57, 27 September 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Lymphoid enhancer-binding factor 1 (LEF1) is a protein that in humans is encoded by the LEF1 gene.[1]
Function
Lymphoid enhancer-binding factor-1 (LEF1) is a 48-kD nuclear protein that is expressed in pre-B and T cells. It binds to a functionally important site in the T-cell receptor-alpha (TCRA) enhancer and confers maximal enhancer activity. LEF1 belongs to a family of regulatory proteins that share homology with high mobility group protein-1 (HMG1).[2]
Clinical significance
LEF1 is highly overexpressed and associated with disease progression and poor prognosis in B-cell chronic lymphocytic leukemia.[3] It is also a promising potential drug target.[4]
Interactions
Lymphoid enhancer-binding factor 1 has been shown to interact with:
References
- ↑ Milatovich A, Travis A, Grosschedl R, Francke U (Mar 1992). "Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf". Genomics. 11 (4): 1040–8. doi:10.1016/0888-7543(91)90030-I. PMID 1783375.
- ↑ "Entrez Gene: LEF1 lymphoid enhancer-binding factor 1".
- ↑ Erdfelder F, Hertweck M, Filipovich A, Uhrmacher S, Kreuzer KA (2010). "High lymphoid enhancer- binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia". Hematology Reports. 2 (1): 3. doi:10.4081/hr.2010.e3.
- ↑ Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA (April 2010). "Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo". Neoplasia. 12 (4): 326–35. PMC 2847740. PMID 20360943.
- ↑ Boras K, Hamel PA (January 2002). "Alx4 binding to LEF-1 regulates N-CAM promoter activity". J. Biol. Chem. 277 (2): 1120–7. doi:10.1074/jbc.M109912200. PMID 11696550.
- ↑ Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW (January 2000). "A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia". J. Biol. Chem. 275 (1): 651–6. doi:10.1074/jbc.275.1.651. PMID 10617663.
- ↑ Edlund S, Lee SY, Grimsby S, Zhang S, Aspenström P, Heldin CH, Landström M (February 2005). "Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis". Mol. Cell. Biol. 25 (4): 1475–88. doi:10.1128/MCB.25.4.1475-1488.2005. PMC 548008. PMID 15684397.
- ↑ Grueneberg DA, Pablo L, Hu KQ, August P, Weng Z, Papkoff J (June 2003). "A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway". Mol. Cell. Biol. 23 (11): 3936–50. doi:10.1128/MCB.23.11.3936-3950.2003. PMC 155208. PMID 12748295.
- ↑ Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (August 1996). "Functional interaction of beta-catenin with the transcription factor LEF-1". Nature. 382 (6592): 638–42. doi:10.1038/382638a0. PMID 8757136.
- ↑ 10.0 10.1 10.2 Labbé E, Letamendia A, Attisano L (July 2000). "Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways". Proc. Natl. Acad. Sci. U.S.A. 97 (15): 8358–63. doi:10.1073/pnas.150152697. PMC 26952. PMID 10890911.
- ↑ Hecht A, Stemmler MP (February 2003). "Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4". J. Biol. Chem. 278 (6): 3776–85. doi:10.1074/jbc.M210081200. PMID 12446687.
- ↑ Yasumoto K, Takeda K, Saito H, Watanabe K, Takahashi K, Shibahara S (June 2002). "Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling". EMBO J. 21 (11): 2703–14. doi:10.1093/emboj/21.11.2703. PMC 126018. PMID 12032083.
- ↑ Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R (December 2001). "PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies". Genes Dev. 15 (23): 3088–103. doi:10.1101/gad.944801. PMC 312834. PMID 11731474.
Further reading
- Waterman ML (2004). "Lymphoid enhancer factor/T cell factor expression in colorectal cancer". Cancer Metastasis Rev. 23 (1–2): 41–52. doi:10.1023/A:1025858928620. PMID 15000148.
- Skokowa J, Welte K (2007). "LEF-1 is a decisive transcription factor in neutrophil granulopoiesis". Ann. N. Y. Acad. Sci. 1106: 143–51. doi:10.1196/annals.1392.012. PMID 17360796.
- Travis A, Amsterdam A, Belanger C, Grosschedl R (1991). "LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]". Genes Dev. 5 (5): 880–94. doi:10.1101/gad.5.5.880. PMID 1827423.
- van de Wetering M, Oosterwegel M, Dooijes D, Clevers H (1991). "Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box". EMBO J. 10 (1): 123–32. PMC 452620. PMID 1989880.
- Waterman ML, Fischer WH, Jones KA (1991). "A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer". Genes Dev. 5 (4): 656–69. doi:10.1101/gad.5.4.656. PMID 2010090.
- Zhou P, Byrne C, Jacobs J, Fuchs E (1995). "Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate". Genes Dev. 9 (6): 700–13. doi:10.1101/gad.9.6.700. PMID 7537238.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Prieve MG, Guttridge KL, Munguia JE, Waterman ML (1996). "The nuclear localization signal of lymphoid enhancer factor-1 is recognized by two differentially expressed Srp1-nuclear localization sequence receptor proteins". J. Biol. Chem. 271 (13): 7654–8. doi:10.1074/jbc.271.13.7654. PMID 8631802.
- Behrens J, von Kries JP, Kühl M, et al. (1996). "Functional interaction of beta-catenin with the transcription factor LEF-1". Nature. 382 (6592): 638–42. doi:10.1038/382638a0. PMID 8757136.
- Bagga R, Emerson BM (1997). "An HMG I/Y-containing repressor complex and supercoiled DNA topology are critical for long-range enhancer-dependent transcription in vitro". Genes Dev. 11 (5): 629–39. doi:10.1101/gad.11.5.629. PMID 9119227.
- Bruhn L, Munnerlyn A, Grosschedl R (1997). "ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function". Genes Dev. 11 (5): 640–53. doi:10.1101/gad.11.5.640. PMID 9119228.
- Brannon M, Gomperts M, Sumoy L, et al. (1997). "A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus". Genes Dev. 11 (18): 2359–70. doi:10.1101/gad.11.18.2359. PMC 316518. PMID 9308964.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Korinek V, Barker N, Willert K, et al. (1998). "Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse". Mol. Cell. Biol. 18 (3): 1248–56. PMC 108837. PMID 9488439.
- Prieve MG, Guttridge KL, Munguia J, Waterman ML (1998). "Differential importin-alpha recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1". Mol. Cell. Biol. 18 (8): 4819–32. PMC 109067. PMID 9671491.
- Levanon D, Goldstein RE, Bernstein Y, et al. (1998). "Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors". Proc. Natl. Acad. Sci. U.S.A. 95 (20): 11590–5. doi:10.1073/pnas.95.20.11590. PMC 21685. PMID 9751710.
- Hovanes K, Li TW, Waterman ML (2000). "The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing". Nucleic Acids Res. 28 (9): 1994–2003. doi:10.1093/nar/28.9.1994. PMC 103301. PMID 10756202.
- Labbé E, Letamendia A, Attisano L (2000). "Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways". Proc. Natl. Acad. Sci. U.S.A. 97 (15): 8358–63. doi:10.1073/pnas.150152697. PMC 26952. PMID 10890911.
- Brantjes H, Roose J, van De Wetering M, Clevers H (2001). "All Tcf HMG box transcription factors interact with Groucho-related co-repressors". Nucleic Acids Res. 29 (7): 1410–9. doi:10.1093/nar/29.7.1410. PMC 31284. PMID 11266540.
External links
- LEF1+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates text from the United States National Library of Medicine, which is in the public domain.